drugset / Trial / NCT02445703

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

NCT02445703

Phase 4 Completed 301 enrolled Sinovac Biotech Co., Ltd
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to compare the immunogenicity and safety of three different immunization schedules of inactivated hepatitis A vaccine (HAV) and/ or combined hepatitis A and B vaccine (HABV) in healthy Chinese infants.

Timeline

Start
2014-05
Primary completion
2015-01
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hepatitis B vaccine Vaccine 5 ug Intramuscular
Subject Hepatitis B vaccine Vaccine 0.5 ml Intramuscular
Subject Hepatitis B vaccine Vaccine 250 iu Intramuscular
Subject Inactivated hepatitis A vaccine Vaccine 0.5 ml Intramuscular
Subject Inactivated hepatitis A vaccine Vaccine 250 iu Intramuscular